Medicinal Product Identification Standards: Ensuring Consistent, Exchangeable Data Across the Healthcare Ecosystem

Delivering reliable, secure, and consistent medicinal product data is more important than ever for companies, regulators, and healthcare IT providers worldwide. As medicinal products traverse complex global supply chains and stringent regulatory environments, establishing a common language and shared data structures for product information has become non-negotiable. The suite of Medicinal Product Identification Standards—ISO 11238:2018, ISO 11240:2012, ISO 11615:2017, and ISO 11616:2017—form the foundational blueprint for consistent and interoperable data exchange. This article explores each standard, unpacks their unique roles, and offers a practical roadmap for adoption, highlighting how implementing these standards can boost productivity, security, scalability, and ultimately strengthen the entire healthcare ecosystem.

Overview / Introduction

Health informatics has emerged as the backbone of modern healthcare, enabling seamless information exchange between systems, regulators, manufacturers, and care providers. Ensuring that medicinal products and their components are accurately and uniquely identified across these digital landscapes is key to patient safety, regulatory compliance, and efficient operations. The rapid evolution of healthcare IT systems, cross-border pharmaceuticals trade, and data-driven regulation has placed a premium on data integrity and interoperability.

Within this context, the ISO suite for medicinal product identification—collectively referred to as IDMP (Identification of Medicinal Products)—provides standardized yet flexible frameworks for how product data is defined, structured, and shared. From the granular details of substances and units of measure to entire regulated products and their lifecycle, these standards ensure all players speak the same language, reduce the risks from data errors, and support scaling business operations effectively. In this guide, you’ll uncover:

• The specific focus and scope of each standard
• Key requirements and implementation benefits
• How these standards improve data security, productivity, and market agility
• Actionable insights for organizations embarking on IDMP compliance

Detailed Standards Coverage

ISO 11238:2018 – Reliable Substance Identification for Regulatory Compliance

Health informatics — Identification of medicinal products — Data elements and structures for the unique identification and exchange of regulated information on substances

In a pharmaceutical world characterized by diverse substances, ranging from simple chemicals to cutting-edge biologics, a robust mechanism for substance identification is pivotal. ISO 11238:2018 delivers a comprehensive information model that defines and uniquely identifies substances within medicinal products—spanning not only drugs, but also dietary supplements, foods, and cosmetics. Its principles are applicable globally and across both human and veterinary domains, supporting regulators, manufacturers, and IT systems with a common framework.

The standard establishes:

• Classification of substances (chemical, protein, nucleic acid, polymers, mixtures)
• Unique identifiers for each substance, irrespective of naming conventions or production methods
• Data models for capturing substance details: structure, source, modifications, reference info, substance codes, and manufacturing data

Implementing ISO 11238:2018 streamlines regulatory submissions, enhances pharmacovigilance, and enables unequivocal identification for global trade and research. It references other standards and supports future expansion via compatible terminologies.

Key highlights:

• Offers a granular, scientific approach to substance identification
• Facilitates traceability, safety, and reliable substance data exchange across borders
• Reduces ambiguity and mapping complexities between jurisdictions

Access the full standard:View ISO 11238:2018 on iTeh Standards

ISO 11240:2012 – Consistent Units of Measurement for Medicinal Products

Health informatics — Identification of medicinal products — Data elements and structures for the unique identification and exchange of units of measurement

Accurate, machine-readable communication of product strength, dosage, and composition relies on a shared understanding of units of measurement. ISO 11240:2012 addresses this by spelling out data structures, usage rules, and coding formats for units in medicinal product information, thus supporting precise, traceable, and standardized documentation essential for both regulatory compliance and clinical safety.

The scope includes:

• Defining rules for units utilized in quantitative medicinal product attributes (e.g., strength)
• Enabling interoperability via mapping between different unit vocabularies and translations
• Recommending traceable links to international metrological standards (such as SI units)
• Facilitating the electronic exchange of unit data between diverse computer applications

This standard is a linchpin for accurate data exchange across siloed systems, ensuring unambiguous communication in product label submissions, pharmacovigilance, supply chain management, and e-prescribing.

Key highlights:

• Establishes globally consistent unit definitions, mapping, and representations
• Ensures machine-readability and automated data processing for units
• Reduces translation errors, safeguarding patient outcomes

Access the full standard:View ISO 11240:2012 on iTeh Standards

ISO 11615:2017 – Comprehensive Framework for Medicinal Product Life Cycle

Health informatics — Identification of medicinal products — Data elements and structures for the unique identification and exchange of regulated medicinal product information

As medicinal products evolve from development through authorization, marketing, and potential withdrawal, it’s critical to accurately track every stage. ISO 11615:2017 details the essential concepts, data elements, and structural relationships required for comprehensive, lifecycle-based identification of regulated medicinal products for human use.

This standard encompasses:

• Unique identification of both authorized and investigational medicinal products
• Data structures supporting medicine registration, batch tracking, packaging, organizational roles, and regulatory authorizations
• Information exchange formatting to enable robust submissions, renewals, updates, and pharmacovigilance
• Strong integration with other IDMP standards and messaging protocols

Adherence to ISO 11615:2017 is vital for streamlined regulatory workflows, efficient information sharing, and real-time monitoring—ultimately improving public health protections and market transparency.

Key highlights:

• Supports end-to-end product lifecycle management
• Enhances compatibility and interoperability between regulatory bodies, sponsors, and manufacturers
• Provides foundational blocks for robust global pharmacovigilance practices

Access the full standard:View ISO 11615:2017 on iTeh Standards

ISO 11616:2017 – Structured Pharmaceutical Product Data for Clinical and Regulatory Excellence

Health informatics — Identification of medicinal products — Data elements and structures for unique identification and exchange of regulated pharmaceutical product information

Clear, unambiguous identification and exchange of regulated pharmaceutical product information are essential for both regulatory activities and clinical utilization. ISO 11616:2017 sets out a highly structured model, defining data elements and their relationships specific to pharmaceutical products, supporting use cases from regulatory submissions to e-prescribing and clinical decision support.

Its focus includes:

• Rules for creating and exchanging uniquely identified pharmaceutical product data structures
• Facilitating global and regional interoperability for product data across regulatory, supply chain, and healthcare provider systems
• Supporting clinical workflows by enabling e-prescribing and decision support with consistent product information
• Integration with broader IDMP frameworks for comprehensive medicinal product safety and management

ISO 11616:2017 underpins the digital transformation of pharmaceutical information management, offering the transparency and reliability the sector demands.

Key highlights:

• Ensures pharmaceutical product data is structured, interoperable, and exchangeable globally
• Streamlines both regulatory procedures and clinical operations
• Tailors information granularity to the needs of multiple stakeholders

Access the full standard:View ISO 11616:2017 on iTeh Standards

Industry Impact & Compliance

Navigating the Compliance Landscape

Adopting these identification standards is no longer a luxury—it’s a competitive and regulatory necessity. Regulatory authorities across the globe now mandate or strongly encourage IDMP-based submissions, especially in jurisdictions like the EU and US. Failure to implement these standards can lead to costly delays in market authorizations, increased risk of product recalls due to data discrepancies, and loss of competitive positioning due to inefficiency.

Business Benefits:

• Enhanced data integrity and reduction of duplication or errors across global supply chains
• Streamlined regulatory filings and faster time-to-market
• Stronger pharmacovigilance through robust, traceable substance and product data
• Interoperability with distributors, partners, and health IT platforms

Risks of Non-Compliance:

• Regulatory penalties, market access delays, or even product withdrawal
• Increased operational costs from uncoordinated and manual data management
• Compromised patient safety and potential reputational harm

The standards provide the foundation for building trust across the digital health ecosystem, ensuring every stakeholder—be it a regulator, hospital, or data platform—can work with consistent, reliable medicinal product information.

Implementation Guidance

Proven Approaches for Successful Adoption

1. Gap Assessment and Planning:

• Evaluate current data models and systems against IDMP requirements
• Engage all internal stakeholders: regulatory affairs, IT, manufacturing, and quality assurance
• Identify gaps and prioritize based on compliance timelines

2. Data Harmonization:

• Integrate substance identifiers, units of measurement, and product data into a unified architecture
• Align legacy data and terminologies with IDMP codes and conventions

3. Technology Enablement:

• Leverage software solutions that support IDMP-compliant data structures and workflows
• Automate mapping, validation, and data exchange where possible

4. Training and Change Management:

• Develop in-house expertise on IDMP standards and their business implications
• Provide training for all system users, from regulatory staff to IT and quality control

5. Continuous Monitoring and Improvement:

• Establish KPIs to measure efficiency gains, data quality improvements, and compliance progress
• Regularly update processes and training as standards evolve

Resources for Organizations

• Access authoritative standards directly via iTeh Standards
• Participate in webinars, workshops, and forums focused on IDMP best practices
• Collaborate with technology vendors experienced in healthcare data standards

Conclusion / Next Steps

Standardizing medicinal product identification is no longer optional—it is fundamental for organizations seeking to scale safely, comply with international regulations, and remain competitive in a digital-first healthcare environment. The four ISO standards covered here—ISO 11238:2018, ISO 11240:2012, ISO 11615:2017, and ISO 11616:2017—equip organizations with the blueprint they need for consistent, reliable, and exchangeable data.

Key Takeaways:

• Uniform identifiers and data models drive productivity, reduce risk, and improve security
• Comprehensive adoption streamlines regulatory processes and unlocks operational efficiencies
• Early, proactive implementation is the best strategy for scaling and future-proofing your business

Recommended Actions:

• Review and obtain the full texts using the direct iTeh Standards links
• Conduct internal readiness assessments
• Engage with industry peers and solution providers to accelerate compliance and value realization

The future of healthcare is data-driven, connected, and global. By building on these standards today, organizations are not only ensuring compliance but also unlocking new possibilities for innovation and patient care.